Panafen IB
Country: New Zealand
Lingwa: Ingliż
Sors: Medsafe (Medicines Safety Authority)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
Ibuprofen 200mg
Disponibbli minn:
GlaxoSmithKline NZ Limited
INN (Isem Internazzjonali):
Ibuprofen 200 mg
Dożaġġ:
200 mg
Għamla farmaċewtika:
Film coated tablet
Kompożizzjoni:
Active: Ibuprofen 200mg Excipient: Colloidal silicon dioxide Croscarmellose sodium Hypromellose Lactose monohydrate Magnesium stearate Maize starch Microcrystalline cellulose Triacetin
Unitajiet fil-pakkett:
Blister pack, PVC/PVDC/Al - 12 tablets, 12 tablets
Klassi:
General sale
Tip ta 'preskrizzjoni:
General sale
Manifatturat minn:
BASF Corporation
Sommarju tal-prodott:
Package - Contents - Shelf Life: Blister pack, PVC/PVDC/Al - 12 tablets - 12 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, PVC/PVDC/Al - 24 tablets - 24 tablets - 24 months from date of manufacture stored at or below 30°C
Data ta 'l-awtorizzazzjoni:
2004-04-30
